WDNA
WisdomTree BioRevolution Fund
Price Chart
Latest Quote
$17.77
-0.62 (-3.36%)
Current Price
| Previous Close | $18.39 |
| Open | $18.17 |
| Day High | $18.22 |
| Day Low | $17.70 |
| Volume | 3,110 |
Fund Information
| Quarterly Dividend / Yield | N/A / 4.20% |
| Net Assets | $2.39M |
| Expense Ratio | 0.45% |
| Category | Health |
| Fund Family | WisdomTree |
| Net Asset Value | $17.79 |
| Premium/Discount | -0.13% |
| Quarterly Dividend Yield | 4.20% |
| P/E Ratio | 21.60 |
| Exchange | BTS |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $17.77 |
| SMA50 | $17.81 |
| SMA200 | $16.82 |
| RSI | 56.48 |
| ATR | 0.3980 |
| Rel Volume | 3.15 |
Performance History
| Week | -3.08% |
| Month | -3.05% |
| Quarter | +1.92% |
| 6 Months | +7.57% |
| YTD | +5.02% |
| Year | +45.45% |
| 3 Years | +10.80% |
| 10 Years | -24.19% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $17.77 | 3,100 |
| 2026-06-04 | $18.39 | 700 |
| 2026-06-03 | $17.86 | 1,100 |
| 2026-06-02 | $17.64 | 1,200 |
| 2026-06-01 | $18.12 | 700 |
| 2026-05-29 | $18.33 | 2,300 |
| 2026-05-28 | $18.36 | 100 |
| 2026-05-27 | $18.01 | 400 |
| 2026-05-26 | $17.79 | 300 |
| 2026-05-22 | $17.56 | 400 |
| 2026-05-21 | $17.55 | 300 |
| 2026-05-20 | $17.36 | 1,300 |
| 2026-05-19 | $16.95 | 200 |
| 2026-05-18 | $17.05 | 2,000 |
| 2026-05-15 | $17.28 | 300 |
| 2026-05-14 | $17.71 | 600 |
| 2026-05-13 | $17.93 | 500 |
| 2026-05-12 | $17.94 | 1,800 |
| 2026-05-11 | $17.87 | 600 |
| 2026-05-08 | $17.89 | 1,800 |
| 2026-05-07 | $17.94 | 1,100 |
| 2026-05-06 | $18.33 | 1,000 |
About WisdomTree BioRevolution Fund
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on WDNA.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.